These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Zhu FC; Guan XH; Li YH; Huang JY; Jiang T; Hou LH; Li JX; Yang BF; Wang L; Wang WJ; Wu SP; Wang Z; Wu XH; Xu JJ; Zhang Z; Jia SY; Wang BS; Hu Y; Liu JJ; Zhang J; Qian XA; Li Q; Pan HX; Jiang HD; Deng P; Gou JB; Wang XW; Wang XH; Chen W Lancet; 2020 Aug; 396(10249):479-488. PubMed ID: 32702299 [TBL] [Abstract][Full Text] [Related]
27. Recombinant SARS-CoV-2 spike S1-Fc fusion protein induced high levels of neutralizing responses in nonhuman primates. Ren W; Sun H; Gao GF; Chen J; Sun S; Zhao R; Gao G; Hu Y; Zhao G; Chen Y; Jin X; Fang F; Chen J; Wang Q; Gong S; Gao W; Sun Y; Su J; He A; Cheng X; Li M; Xia C; Li M; Sun L Vaccine; 2020 Jul; 38(35):5653-5658. PubMed ID: 32651113 [TBL] [Abstract][Full Text] [Related]
28. An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques. Feng L; Wang Q; Shan C; Yang C; Feng Y; Wu J; Liu X; Zhou Y; Jiang R; Hu P; Liu X; Zhang F; Li P; Niu X; Liu Y; Zheng X; Luo J; Sun J; Gu Y; Liu B; Xu Y; Li C; Pan W; Zhao J; Ke C; Chen X; Xu T; Zhong N; Guan S; Yuan Z; Chen L Nat Commun; 2020 Aug; 11(1):4207. PubMed ID: 32826924 [TBL] [Abstract][Full Text] [Related]
29. Heterologous prime-boost vaccination with adenoviral vector and protein nanoparticles induces both Th1 and Th2 responses against Middle East respiratory syndrome coronavirus. Jung SY; Kang KW; Lee EY; Seo DW; Kim HL; Kim H; Kwon T; Park HL; Kim H; Lee SM; Nam JH Vaccine; 2018 Jun; 36(24):3468-3476. PubMed ID: 29739720 [TBL] [Abstract][Full Text] [Related]
30. Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity. Scaglione A; Opp S; Hurtado A; Lin Z; Pampeno C; Noval MG; Thannickal SA; Stapleford KA; Meruelo D Front Immunol; 2021; 12():719077. PubMed ID: 34394127 [TBL] [Abstract][Full Text] [Related]
31. Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses. Gupta T; Gupta SK Int Immunopharmacol; 2020 Sep; 86():106717. PubMed ID: 32585611 [TBL] [Abstract][Full Text] [Related]
33. Functional mapping of B-cell linear epitopes of SARS-CoV-2 in COVID-19 convalescent population. Yi Z; Ling Y; Zhang X; Chen J; Hu K; Wang Y; Song W; Ying T; Zhang R; Lu H; Yuan Z Emerg Microbes Infect; 2020 Dec; 9(1):1988-1996. PubMed ID: 32844713 [No Abstract] [Full Text] [Related]
34. A Thermostable mRNA Vaccine against COVID-19. Zhang NN; Li XF; Deng YQ; Zhao H; Huang YJ; Yang G; Huang WJ; Gao P; Zhou C; Zhang RR; Guo Y; Sun SH; Fan H; Zu SL; Chen Q; He Q; Cao TS; Huang XY; Qiu HY; Nie JH; Jiang Y; Yan HY; Ye Q; Zhong X; Xue XL; Zha ZY; Zhou D; Yang X; Wang YC; Ying B; Qin CF Cell; 2020 Sep; 182(5):1271-1283.e16. PubMed ID: 32795413 [TBL] [Abstract][Full Text] [Related]
35. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. Xia S; Duan K; Zhang Y; Zhao D; Zhang H; Xie Z; Li X; Peng C; Zhang Y; Zhang W; Yang Y; Chen W; Gao X; You W; Wang X; Wang Z; Shi Z; Wang Y; Yang X; Zhang L; Huang L; Wang Q; Lu J; Yang Y; Guo J; Zhou W; Wan X; Wu C; Wang W; Huang S; Du J; Meng Z; Pan A; Yuan Z; Shen S; Guo W; Yang X JAMA; 2020 Sep; 324(10):951-960. PubMed ID: 32789505 [TBL] [Abstract][Full Text] [Related]
36. An Effective COVID-19 Vaccine Needs to Engage T Cells. Sauer K; Harris T Front Immunol; 2020; 11():581807. PubMed ID: 33117391 [No Abstract] [Full Text] [Related]
37. Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice. Martinez DR; Schäfer A; Leist SR; De la Cruz G; West A; Atochina-Vasserman EN; Lindesmith LC; Pardi N; Parks R; Barr M; Li D; Yount B; Saunders KO; Weissman D; Haynes BF; Montgomery SA; Baric RS Science; 2021 Aug; 373(6558):991-998. PubMed ID: 34214046 [TBL] [Abstract][Full Text] [Related]
38. Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice. Liu X; Drelich A; Li W; Chen C; Sun Z; Shi M; Adams C; Mellors JW; Tseng CT; Dimitrov DS Vaccine; 2020 Oct; 38(46):7205-7212. PubMed ID: 33010978 [TBL] [Abstract][Full Text] [Related]
39. What the immune response to the coronavirus says about the prospects for a vaccine. Ledford H Nature; 2020 Sep; 585(7823):20-21. PubMed ID: 32811981 [No Abstract] [Full Text] [Related]
40. Coronavirus vaccines get a biotech boost. Dance A Nature; 2020 Jul; 583(7817):647-649. PubMed ID: 32694847 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]